Caseware UK (AP4) 2025.0.111 2025.0.111 2025-08-312025-08-310false2024-09-01true0truefalse 10320763 2024-09-01 2025-08-31 10320763 2023-09-01 2024-08-31 10320763 2025-08-31 10320763 2024-08-31 10320763 c:Director1 2024-09-01 2025-08-31 10320763 d:ShareCapital 2025-08-31 10320763 d:ShareCapital 2024-08-31 10320763 c:EntityHasNeverTraded 2024-09-01 2025-08-31 10320763 c:FRS102 2024-09-01 2025-08-31 10320763 c:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 10320763 c:FullAccounts 2024-09-01 2025-08-31 10320763 c:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 10320763 6 2024-09-01 2025-08-31 10320763 e:PoundSterling 2024-09-01 2025-08-31 iso4217:GBP xbrli:pure

Registered number: 10320763










C K HEALTHCARE LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 AUGUST 2025

 
C K HEALTHCARE LIMITED
REGISTERED NUMBER: 10320763

BALANCE SHEET
AS AT 31 AUGUST 2025

2025
2024
Note
£
£

Fixed assets
  

Investments
 3 
99
99

  
99
99

Current assets
  

Cash at bank and in hand
 4 
1
1

  
1
1

Total assets less current liabilities
  
 
 
100
 
 
100

  

Net assets
  
100
100


Capital and reserves
  

Called up share capital 
  
100
100

  
100
100


For the year ended 31 August 2025 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 12 August 2026.




Mr D G Jarvis
Director

The notes on pages 2 to 3 form part of these financial statements.

Page 1

 
C K HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

1.


General information

CK Healthcare Limited is a private company limited by shares incorporated in England and Wales, registration number 10320763. The registered office is Lakeside House, Kingfisher Way, Stockton-on-Tees, TS18 3NB. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

 
2.2

Exemption from preparing consolidated financial statements

The Company, and the Group headed by it, qualify as small as set out in section 383 of the Companies Act 2006 and the parent and Group are considered eligible for the exemption to prepare consolidated accounts.

 
2.3

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.4

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.


3.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 September 2024
99



At 31 August 2025
99




Page 2

 
C K HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025

4.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
1
1

1
1


Page 3